Cotización HedgePath Pharmaceuticals Inc
Acciones
US42278K1025
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13/12/22 |
Amy M. McCord
LAW | General Counsel | - | 01/01/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
Samuel P. Sears
BRD | Director/Board Member | 80 | 02/08/13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23/08/23 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,11 % | 45,97 mil M | |
+52,39 % | 43,93 mil M | |
+7,37 % | 42,34 mil M | |
-8,78 % | 28,27 mil M | |
+18,13 % | 27,18 mil M | |
-20,93 % | 19,44 mil M | |
+14,77 % | 13,83 mil M | |
+31,89 % | 12,4 mil M | |
+8,77 % | 11,45 mil M |